Masimo Corporation $MASI Shares Sold by TD Asset Management Inc

TD Asset Management Inc reduced its holdings in shares of Masimo Corporation (NASDAQ:MASIFree Report) by 35.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 107,858 shares of the medical equipment provider’s stock after selling 59,318 shares during the period. TD Asset Management Inc owned about 0.20% of Masimo worth $15,914,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. MAI Capital Management boosted its stake in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 129 shares during the period. Smartleaf Asset Management LLC lifted its stake in Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 136 shares during the last quarter. Allworth Financial LP grew its holdings in Masimo by 72.8% during the 2nd quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 163 shares in the last quarter. Clearstead Advisors LLC grew its holdings in Masimo by 18.4% during the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after acquiring an additional 73 shares in the last quarter. Finally, Hantz Financial Services Inc. increased its position in shares of Masimo by 792.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 580 shares of the medical equipment provider’s stock valued at $86,000 after purchasing an additional 515 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Performance

NASDAQ MASI opened at $175.35 on Monday. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of -16.64, a PEG ratio of 1.78 and a beta of 1.21. The business’s 50 day moving average is $143.09 and its two-hundred day moving average is $143.94. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $194.88. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Bank of America began coverage on shares of Masimo in a research note on Monday, November 17th. They issued a “neutral” rating and a $162.00 price target on the stock. Wells Fargo & Company downgraded shares of Masimo from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $190.00 to $180.00 in a research report on Wednesday, February 18th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research report on Tuesday, February 17th. Finally, Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $181.17.

Check Out Our Latest Report on Masimo

Masimo Company Profile

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Featured Articles

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.